ACADIAN ASSET MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$5,989,000
-69.2%
180,979
-60.4%
0.02%
-65.8%
Q4 2021$19,462,000
+15.8%
457,580
+20.7%
0.07%
+14.1%
Q3 2021$16,801,000
+46.3%
379,245
+87.6%
0.06%
+48.8%
Q2 2021$11,483,000
+64.9%
202,143
+117.2%
0.04%
+59.3%
Q1 2021$6,965,000
+22367.7%
93,050
+25819.2%
0.03%
Q4 2020$31,000
+19.2%
359
-41.5%
0.00%
Q2 2020$26,0006140.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders